United Therapeutics Scheduled to Report Q3 2026 Earnings on November 4
United Therapeutics (UTHR) is set to release its third-quarter 2026 financial results on Wednesday, November 4, prior to the market opening. Investors are closely watching for performance metrics against consensus expectations. The market anticipates an earnings per share (EPS) of $6.34 and total revenue of approximately $781.14 million. The projected revenue represents a year-over-year decline of 2.3%, signaling potential headwinds or shifts in the company's current product cycle.
Tickers: $UTHR